• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.

作者信息

Van Roy N, Cheng N C, Laureys G, Opdenakker G, Versteeg R, Speleman F

机构信息

Department of Medical Genetics, University Hospital Ghent, Belgium.

出版信息

Eur J Cancer. 1995;31A(4):530-5. doi: 10.1016/0959-8049(95)00004-3.

DOI:10.1016/0959-8049(95)00004-3
PMID:7576960
Abstract

Loss of chromosome 1 short arm material, resulting from terminal deletions or unbalanced translocations, is a frequent finding in advanced neuroblastoma. In translocations, often relatively small portions of a second chromosome are translocated to the chromosome 1 short arm. The chromosomal origin of this translocated material could often not be identified using banding analysis only. Recent studies, applying fluorescent in situ hybridisation, showed that in the majority of these translocations, chromosome 17 is involved. In this study, the nonrandom occurrence of unbalanced 1;17 translocations is further supported by their presence in 3/7 neuroblastoma cell lines. Analysis of the 1p breakpoints extends our earlier observation of breakpoint heterogeneity. A similar scattering of 17q breakpoints was observed. The 1p and 17q breakpoints of the constitutional 1;17 translocation did not coincide with any of the 1;17 translocation breakpoints found in neuroblastoma cell lines. Cell lines, not containing 1;17 translocations, contained other chromosome 17 rearrangements. As a result, extra copies of 17q are found in all cell lines, suggesting a role for genes on 17q in neuroblastoma development. The possible significance of 1;17 translocations in neuroblastoma is discussed.

摘要

相似文献

1
Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.
Eur J Cancer. 1995;31A(4):530-5. doi: 10.1016/0959-8049(95)00004-3.
2
Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.神经母细胞瘤中1;17易位断点的分析:对神经母细胞瘤基因定位的意义
Eur J Cancer. 1997 Oct;33(12):1974-8. doi: 10.1016/s0959-8049(97)00319-5.
3
Promiscuous translocations of chromosome arm 17q in human neuroblastomas.人类神经母细胞瘤中17号染色体长臂的杂乱易位。
Genes Chromosomes Cancer. 1997 Jul;19(3):143-9.
4
Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastoma.
Eur J Cancer. 1995;31A(4):523-6. doi: 10.1016/0959-8049(95)00012-8.
5
Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.神经母细胞瘤中17q易位断点的分子细胞遗传学定义
Med Pediatr Oncol. 2001 Jan;36(1):20-3. doi: 10.1002/1096-911X(20010101)36:1<20::AID-MPO1006>3.0.CO;2-E.
6
Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.神经母细胞瘤细胞系中17q易位断点的分子细胞遗传学描绘
Genes Chromosomes Cancer. 1998 Oct;23(2):116-22. doi: 10.1002/(sici)1098-2264(199810)23:2<116::aid-gcc4>3.0.co;2-5.
7
der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY).der(11)t(11;17):晚期神经母细胞瘤(NBL)的一种独特细胞遗传学途径——通过光谱核型分析(SKY)检测到。
Cancer Lett. 2003 Jul 18;197(1-2):75-9. doi: 10.1016/s0304-3835(03)00083-1.
8
Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.神经母细胞瘤中复杂不平衡易位的逐步发生,导致端粒序列插入和晚期17号染色体长臂获得。
Oncogene. 2005 May 5;24(20):3377-84. doi: 10.1038/sj.onc.1208486.
9
Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.涉及1p和17q的易位是人类神经母细胞瘤细胞反复出现的基因改变。
Am J Hum Genet. 1994 Aug;55(2):334-40.
10
Variety and complexity of chromosome 17 translocations in neuroblastoma.神经母细胞瘤中17号染色体易位的多样性和复杂性。
Genes Chromosomes Cancer. 2004 Feb;39(2):143-50. doi: 10.1002/gcc.10313.

引用本文的文献

1
17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications.神经母细胞瘤中17号染色体长臂增益:临床和生物学意义综述
Cancers (Basel). 2024 Jan 12;16(2):338. doi: 10.3390/cancers16020338.
2
From DNA Copy Number Gains and Tumor Dependencies to Novel Therapeutic Targets for High-Risk Neuroblastoma.从DNA拷贝数增加和肿瘤依赖性到高危神经母细胞瘤的新型治疗靶点
J Pers Med. 2021 Dec 3;11(12):1286. doi: 10.3390/jpm11121286.
3
The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.遗传和表观遗传改变在神经母细胞瘤发病机制中的作用。
Pediatr Surg Int. 2013 Feb;29(2):101-19. doi: 10.1007/s00383-012-3239-7. Epub 2012 Dec 29.
4
Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.新型靶向 IGF-1R/PI3K 通路的药物可抑制部分髓母细胞瘤和神经母细胞瘤的细胞增殖和存活。
PLoS One. 2012;7(10):e47109. doi: 10.1371/journal.pone.0047109. Epub 2012 Oct 8.
5
Neuroblastoma tumour genetics: clinical and biological aspects.神经母细胞瘤肿瘤遗传学:临床与生物学方面
J Clin Pathol. 2001 Dec;54(12):897-910. doi: 10.1136/jcp.54.12.897.
6
New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').新型胸苷酸合成酶抑制剂雷替曲塞(“拓优得”)在癌症治疗中的新进展。
Br J Cancer. 1998;77 Suppl 2(Suppl 2):29-37. doi: 10.1038/bjc.1998.423.
7
Prognostic significance of the proliferative activity in neuroblastoma.神经母细胞瘤增殖活性的预后意义
Am J Pathol. 1997 Jan;150(1):133-45.